Q&A: Liquid crystal nanoparticles enhance antibiotics to reduce CF lung infections
In addition to suffering with cystic fibrosis, patients with this condition often contract lung infections that are difficult to treat; however, an upcoming study may reveal a way to lower infection prevalence.According to a press release from the University of South Australia (UniSA), researchers at the university are looking into liquid crystal nanoparticles as a delivery system for antibiotics